CN116570555A - 一种妇科用导光凝胶及其制备方法 - Google Patents
一种妇科用导光凝胶及其制备方法 Download PDFInfo
- Publication number
- CN116570555A CN116570555A CN202310667872.2A CN202310667872A CN116570555A CN 116570555 A CN116570555 A CN 116570555A CN 202310667872 A CN202310667872 A CN 202310667872A CN 116570555 A CN116570555 A CN 116570555A
- Authority
- CN
- China
- Prior art keywords
- parts
- gel
- light guide
- gynecological
- vaseline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 238000001879 gelation Methods 0.000 title description 2
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims description 41
- 239000004863 Frankincense Substances 0.000 claims description 24
- 229940099259 vaseline Drugs 0.000 claims description 24
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 20
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 20
- 244000020518 Carthamus tinctorius Species 0.000 claims description 18
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 18
- 244000144730 Amygdalus persica Species 0.000 claims description 17
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 17
- 235000006965 Commiphora myrrha Nutrition 0.000 claims description 16
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 16
- 240000007311 Commiphora myrrha Species 0.000 claims description 15
- 241000717739 Boswellia sacra Species 0.000 claims description 14
- 235000003717 Boswellia sacra Nutrition 0.000 claims description 14
- 235000012035 Boswellia serrata Nutrition 0.000 claims description 14
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 14
- 235000011477 liquorice Nutrition 0.000 claims description 14
- 241000628997 Flos Species 0.000 claims description 9
- 241001057584 Myrrha Species 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 208000002193 Pain Diseases 0.000 abstract description 41
- 230000000694 effects Effects 0.000 abstract description 26
- 239000008280 blood Substances 0.000 abstract description 24
- 210000004369 blood Anatomy 0.000 abstract description 24
- 230000017531 blood circulation Effects 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 13
- 239000003814 drug Substances 0.000 abstract description 9
- 230000003213 activating effect Effects 0.000 abstract description 8
- 238000005469 granulation Methods 0.000 abstract description 8
- 230000003179 granulation Effects 0.000 abstract description 8
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 241000894006 Bacteria Species 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 3
- 230000012010 growth Effects 0.000 abstract description 3
- 241000222122 Candida albicans Species 0.000 abstract description 2
- 241000588724 Escherichia coli Species 0.000 abstract description 2
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 2
- 229940095731 candida albicans Drugs 0.000 abstract description 2
- 240000007551 Boswellia serrata Species 0.000 description 12
- 206010011224 Cough Diseases 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 9
- 206010042674 Swelling Diseases 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 7
- 238000005303 weighing Methods 0.000 description 6
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 235000017443 Hedysarum boreale Nutrition 0.000 description 5
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 235000018062 Boswellia Nutrition 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 238000009098 adjuvant therapy Methods 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000304531 Allium macrostemon Species 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000164480 Curcuma aromatica Species 0.000 description 1
- 235000003398 Curcuma aromatica Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920000175 Pistacia lentiscus Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明本发明涉及妇科药品技术领域,具体涉及一种妇科用导光凝胶及其制备方法。本发明提供的一种妇科用导光凝胶由以下原料制成:乳香、没药、红花、桃仁、甘草和凡士林,与现有技术相比,本发明不仅满足现在导光凝胶能够缓和疼痛的作用,同时还具备一定的药理性,能够很好的抑制细菌的生长,尤其是金黄色葡萄球菌、大肠杆菌和白色念珠菌,同时还具备活血止痛、消肿生肌、理气止疼和活血祛瘀等效果。同时该发明还提供了一种妇科用导光凝胶的制备方法,该制作方法简单,操作便捷,非常实用适合推广。
Description
技术领域
本发明涉及妇科药品技术领域,具体涉及一种妇科用导光凝胶及其制备方法。
背景技术
医用导光凝胶是高分子凝胶组成的医用产品,可湿润皮肤,消除皮肤表面空气,润滑性能好,用于光子治疗过程中隔热和导光,与光子治疗设备配合使用。
但是现有的导光凝胶一般多为采用纯化水、甘油、卡波姆组成,虽然同样具备上述效果,但是,患者在进行治疗时,往往还有如激光等因为造成皮肤表面温度升高而产生损害以及疼痛感较强的手段,此时,则需要导光凝胶能够更好的缓和疼痛来缓解用户不适感,以及提升导光率来增加治疗效率。但是现有的导光凝胶产品不含有发挥药理学,往往功能较为单一,不能起到很好的抑菌治疗效果。
发明内容
为了解决上述技术问题,本发明的目的在于提供一种抑菌效果好的妇科用导光凝胶及其制备方法,从中药组方入手,结合的中医药理论知识和中医临床经验,精心配制药材,通过临床实践进行反复摸索和调整,最终发明一个全新的组合配方,它不仅满足现在导光凝胶能够缓和疼痛的作用,同时还具备一定的药理性,能够很好的抑制细菌的生长,同时还具备活血止痛、消肿生肌、理气止疼和活血祛瘀等效果。
本发明采用的技术方案为:一种妇科用导光凝胶,由以下重量份的原料制成:乳香5-25份、没药5-25份、红花2-20份、桃仁5-25份、甘草3-17份、凡士林30-60份。
如上所述的一种妇科用导光凝胶,进一步说明为,由以下重量份的原料制成:乳香10-20份、没药10-20份、红花8-15份、桃仁10-20份、甘草5-13份、凡士林40-50份。
如上所述的一种妇科用导光凝胶,进一步说明为,由以下重量份的原料制成:乳香15份、没药15份、红花12份、桃仁15份、甘草9份、凡士林45份。
如上所述的一种妇科用导光凝胶,进一步说明为,由以下重量份的原料制成:乳香12份、没药14份、红花13份、桃仁16份、甘草19份、凡士林48份。
本发明还相应提供了一种妇科用导光凝胶的制备方法,包括以下步骤:
a、将乳香、没药、红花、桃仁、甘草进行混合均匀得到混合物;
b、将步骤a中的混合物粉碎并过50-150目筛,得混合物细粉;
c、向步骤b中的混合物细粉中加入凡士林,再利用搅拌装置搅拌均匀制成凝胶;
d、将步骤c中的凝胶静止1h后,消除凝胶表面气泡。
本发明所述的中药均为《中华医药大典》所记载的标准中药。
本发明的使用方法:本产品在使用时,使用推注器配合使用,将产品一次性推进阴道底部即可,使用方便快捷。
在使用时,皮肤过敏、皮肤异常与皮肤破损者禁用本产品。
贮藏方法:密封,置于阴凉干燥避光处保存。
注意事项:月经期禁用;过敏体质者慎用;
请置于儿童接触不到的地方、不得用于性生活中对性病的预防、禁用于破损皮肤、粘膜和眼、唇、口腔处粘膜;避免接触外阴皮肤,如有小量产品外流至外阴部,请及时擦拭清洗。
本发明其中药解如下:
乳香:乳香具有活血止痛、通经、外用消肿生肌等功效。乳香是橄榄科小乔木卡氏乳香树,及其同属植物皮部渗出的树脂。呈长卵形滴乳状、类圆形颗粒或粘合成大小不等的不规则块状物,破碎面有玻璃样或蜡样光泽。其性味辛、苦、温,归心、肝、脾经,具有活血止痛、消肿生肌、通经等功效。性味辛、苦、温,气芳香,辛能发散,苦能破,温能通,芳香走窜,入心、肝、脾经,入血分,故能活血止痛,常用治疗风湿痹痛、心腹疼痛、跌打伤痛等病症。具有消肿生肌的作用,临床可用来治疗痈疮肿毒、瘾疹痒毒,改善红、肿、热、痛、破溃等皮肤相关症状。还可以通经止痛,用以治疗气血瘀滞、痛经、经闭、产后瘀血、刺痛等症。
没药消肿生肌、理气止疼、活血祛瘀,源于橄榄科植物地丁树或哈地丁树的干燥树脂。性味辛、苦、平。归心经、肝经和脾经,具有消肿生肌、理气止疼、活血祛瘀的功效;具有消肿止痛的功效。能够生肌、敛疮收口,是治疗跌打损伤、瘀肿疼痛、外科疮疡肿痛的常用药物;具有理气止痛的功效。心腹瘀痛、风湿痹痛、瘀血痛经、血瘀胸痹证、气滞血瘀胃疼、腰腿肩臂疼痛麻木、关节屈伸不利等,均可用没药治疗;没药苦辛,药性相对平和,可以行散气滞、活血祛瘀、止痛,所以常常和乳香配伍相须为用,用于治疗气行不畅、瘀血阻滞所导致的胸痹心痛,胃脘疼痛以及瘀滞、痛经、经闭,产后腹痛等症状,尤其擅长于治疗胃脘疼痛。
红花活血通经、散瘀止痛。红花辛、温,归于心、肝二经,是跌打损伤、疮疡肿痛的主要药物;红花的功效是活血通经、散瘀止痛,主要用于月经不调、痛经、产后恶露不行、症瘕痞块、肿块等,是妇科的主要药物;红花有活血通经、散瘀止痛,对于气滞血瘀所致的瘀滞腹痛、胁胀刺痛、心经乳房胀痛,可以配伍柴胡、郁金药物,效果会更好,因为寒凝血瘀导致的胸痹,也可以配伍肉桂、丹参、薤白等,治疗效果会更好。
桃仁的功效与作用润肠通便、活血化瘀、止咳平喘。质润,有润肠通便的功效,可以缓解肠燥引起的大便干结、排便困难、腹部疼痛、腹胀等症状;由于桃仁味苦能降泄,活血祛瘀功效较强,有助于治疗血滞引起的经闭、痛经,产后瘀滞、腹痛等病症以及跌打损伤引起的淤血肿痛。现代药理研究发现,桃仁中含有的苦杏仁苷具有止咳平喘的功效,有助于缓解咳嗽、气喘等症状。
甘草补脾益气、祛痰止咳、止痛。甘草味甘平,入心、肺、脾、胃经。有益气复脉的功效,蜜炙后补气之力增强。可用于辅助治疗心气不足、心悸、脉郁。清热解毒:甘草性味甘凉,能清热解毒。可用于辅助治疗咽喉肿痛、痈肿疮毒。炙甘草性温,一般不用于清热解毒;祛痰止咳:甘草性质平淡,药性温和。能化痰止咳,益气润肺。无论外感内伤,寒热虚实,新症久咳均可使用。可用于治疗风寒咳嗽、风热咳嗽、寒痰咳嗽、湿痰咳嗽、肺燥咳嗽;止痛:甘草入中焦有健脾和胃、止疼止痛的功效。可用于治疗脾胃气虚、乏力、纳差、便溏、腹胀或四肢急性疼痛。
凡士林是一种化学惰性碳氢化合物。它没有杀菌能力,也不亲水。一般来说不会被吸收。涂抹在皮肤上,能在皮肤表面形成一层薄膜,使水分不易蒸发,保持皮肤湿润。还能阻断空气中的细菌与皮肤的接触,从而降低感染的可能性;凡士林涂在身体各个部位,起到保湿滋润的作用。用来做一些发乳,发油,护肤油。此外,在伤口部位使用凡士林,可以滋润皮肤组织,有效减少与空气的接触,保持身体的自我修复能力,不易留下疤痕,还可以用来预防纸尿裤引起的湿疹,是一种矿物蜡,能在皮肤表面产生一层保护膜。是从石油产品中提取的额外矿物油,最关键是保湿补水;也可以作为补水霜使用,长期使用不易产生副作用、阻断空气中的细菌与皮肤的接触等。
本发明经临床治疗40多例妇科患者,治愈率达90%,有效率达95%,例如:山东省寿光市魏秋枫、53岁,宫颈炎、宫颈糜烂。用本产品凝胶2天见效,半月治愈。
本发明的有益效果是:与现有技术相比,不仅满足现在导光凝胶能够缓和疼痛的作用,同时还具备一定的药理性,能够很好的抑制细菌的生长,尤其是金黄色葡萄球菌、大肠杆菌和白色念珠菌,同时还具备活血止痛、消肿生肌、理气止疼和活血祛瘀等效果。
具体实施方式
下面结合实施例对本发明实施方式做进一步的阐述。
实施例1
本实施例提供的一种妇科用导光凝胶,称取以下重量的原料:乳香5g、没药5g、红花2g、桃仁5g、甘草3g、凡士林30g。
然后由下述方法制成:
a、将乳香、没药、红花、桃仁、甘草进行混合均匀得到混合物;
b、将步骤a中的混合物粉碎并过150目筛,得混合物细粉;
c、向步骤b中的混合物细粉中加入凡士林,再利用搅拌装置搅拌均匀制成凝胶;
d、将步骤c中的凝胶静止1h后,消除凝胶表面气泡。
实施例2
本实施例提供的一种妇科用导光凝胶,称取以下重量的原料:乳香25g、没药25g、红花20g、桃仁25g、甘草17g、凡士林60g。
然后由下述方法制成:
a、将乳香、没药、红花、桃仁、甘草进行混合均匀得到混合物;
b、将步骤a中的混合物粉碎并过50目筛,得混合物细粉;
c、向步骤b中的混合物细粉中加入凡士林,再利用搅拌装置搅拌均匀制成凝胶;
d、将步骤c中的凝胶静止1h后,消除凝胶表面气泡。
实施例3
本实施例提供的一种妇科用导光凝胶,称取以下重量的原料:乳香10g、没药10g、红花8g、桃仁10g、甘草5g、凡士林40g。
然后由下述方法制成:
a、将乳香、没药、红花、桃仁、甘草进行混合均匀得到混合物;
b、将步骤a中的混合物粉碎并过70目筛,得混合物细粉;
c、向步骤b中的混合物细粉中加入凡士林,再利用搅拌装置搅拌均匀制成凝胶;
d、将步骤c中的凝胶静止1h后,消除凝胶表面气泡。
实施例4
本实施例提供的一种妇科用导光凝胶,称取以下重量的原料:乳香20g、没药20g、红花15g、桃仁20g、甘草13g、凡士林50g。
然后由下述方法制成:
a、将乳香、没药、红花、桃仁、甘草进行混合均匀得到混合物;
b、将步骤a中的混合物粉碎并过80目筛,得混合物细粉;
c、向步骤b中的混合物细粉中加入凡士林,再利用搅拌装置搅拌均匀制成凝胶;
d、将步骤c中的凝胶静止1h后,消除凝胶表面气泡。
实施例5
本实施例提供的一种妇科用导光凝胶,称取以下重量的原料:乳香15g、没药15g、红花12g、桃仁15g、甘草9g、凡士林45g。
然后由下述方法制成:
a、将乳香、没药、红花、桃仁、甘草进行混合均匀得到混合物;
b、将步骤a中的混合物粉碎并过100目筛,得混合物细粉;
c、向步骤b中的混合物细粉中加入凡士林,再利用搅拌装置搅拌均匀制成凝胶;
d、将步骤c中的凝胶静止1h后,消除凝胶表面气泡。
实施例6
本实施例提供的一种妇科用导光凝胶,称取以下重量的原料:乳香12g、没药14g、红花13g、桃仁16g、甘草19g、凡士林48g。
然后由下述方法制成:
a、将乳香、没药、红花、桃仁、甘草进行混合均匀得到混合物;
b、将步骤a中的混合物粉碎并过120目筛,得混合物细粉;
c、向步骤b中的混合物细粉中加入凡士林,再利用搅拌装置搅拌均匀制成凝胶;
d、将步骤c中的凝胶静止1h后,消除凝胶表面气泡。
本发明并不限于上述实施例,在本发明的权利要求书所限定的范围内,本领域技术人员不经创造性劳动即可做出的各种变形或修改均受本专利的保护。
Claims (5)
1.一种妇科用导光凝胶,其特征在于,由以下重量份的原料制成:乳香5-25份、没药5-25份、红花2-20份、桃仁5-25份、甘草3-17份、凡士林30-60份。
2.根据权利要求1所述的一种妇科用导光凝胶,其特征在于,由以下重量份的原料制成:乳香10-20份、没药10-20份、红花8-15份、桃仁10-20份、甘草5-13份、凡士林40-50份。
3.根据权利要求1所述的一种妇科用导光凝胶,其特征在于,由以下重量份的原料制成:乳香15份、没药15份、红花12份、桃仁15份、甘草9份、凡士林45份。
4.根据权利要求1所述的一种妇科用导光凝胶,其特征在于,由以下重量份的原料制成:乳香12份、没药14份、红花13份、桃仁16份、甘草19份、凡士林48份。
5.根据权利要求1、2、3或4所述的一种妇科用导光凝胶的制备方法,其特征在于,包括以下步骤:
a、将乳香、没药、红花、桃仁、甘草进行混合均匀得到混合物;
b、将步骤a中的混合物粉碎并过50-150目筛,得混合物细粉;
c、向步骤b中的混合物细粉中加入凡士林,再利用搅拌装置搅拌均匀制成凝胶;
d、将步骤c中的凝胶静止1h后,消除凝胶表面气泡。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310667872.2A CN116570555A (zh) | 2023-06-07 | 2023-06-07 | 一种妇科用导光凝胶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310667872.2A CN116570555A (zh) | 2023-06-07 | 2023-06-07 | 一种妇科用导光凝胶及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116570555A true CN116570555A (zh) | 2023-08-11 |
Family
ID=87537813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310667872.2A Pending CN116570555A (zh) | 2023-06-07 | 2023-06-07 | 一种妇科用导光凝胶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116570555A (zh) |
-
2023
- 2023-06-07 CN CN202310667872.2A patent/CN116570555A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101164574B (zh) | 一种治疗烧伤烫伤的药物及其制备方法 | |
CN104857312A (zh) | 一种防治伤口感染促进伤口愈合的中药组合物 | |
CN101204529A (zh) | 治疗疮伤和消瘢的药物 | |
CN102526411B (zh) | 一种治疗外科伤口的中药组合物 | |
CN104288504A (zh) | 一种治疗烧伤、烫伤的中药软膏制剂及其制备方法 | |
CN108853287A (zh) | 一种抗人乳头瘤病毒及抗妇科炎症的药物组合物、凝胶制剂及应用 | |
CN106581439A (zh) | 一种治疗创伤、糖尿病足和皮肤溃烂的中药组合物及其制备方法 | |
CN101850092A (zh) | 一种治疗外伤的药物及其制备方法 | |
WO2012100754A1 (zh) | 一种治疗刀伤、烧伤及多种创伤中药组合物 | |
CN102784316B (zh) | 治烧烫伤、内外溃疡、白内障的抑癌生肌药及其制备方法 | |
CN107007761B (zh) | 一种中药烧伤油及其制备方法 | |
CN104587206A (zh) | 治疗褥疮的药物及制备方法 | |
CN104623457B (zh) | 缩阴排毒祛斑凝胶剂及其制备方法 | |
CN116570555A (zh) | 一种妇科用导光凝胶及其制备方法 | |
CN102836306B (zh) | 一种治疗马跌打损伤的中药组合物及其制备方法 | |
CN112007101A (zh) | 丁香抑菌液 | |
CN112156225A (zh) | 一种壳聚糖或和海藻多糖复合生物基质液体敷料凝胶制剂及其制备方法 | |
CN105687797A (zh) | 一种用于治疗烧烫伤的药物制剂及其用途 | |
CN111658711A (zh) | 一种治疗烧烫伤的中药配方 | |
CN101513478B (zh) | 一种治疗ⅲ期脉管炎的外敷药膏 | |
CN110624032A (zh) | 一种治疗烧烫伤的膏剂及其制备方法 | |
CN106166209B (zh) | 用于促进i期、ii期压疮愈合、预防压疮iii期的消炎粉 | |
CN100355437C (zh) | 一种治疗烧烫伤的药物及其制备方法 | |
CN108686080A (zh) | 一种褥疮膏及其制备方法 | |
CN109847020A (zh) | 一种用于妇科炎症、缩阴的中药组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |